CAPRICOR THERAPEUTICS INC. - COMMON STOCK

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

24 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics to Present at Upcoming Investor Conferences

21 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

06 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

29 فبراير 2024 15:05:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

27 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29

22 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization

20 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2

24 يناير 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial of CAP-1002 in Duchenne Muscular Dystrophy Based on Completion of Interim Futility Analysis

11 ديسمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

14 نوفمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

10 نوفمبر 2023 09:26:11 بحسب NetDania Notify

Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14

07 نوفمبر 2023 08:15:00 بحسب Nasdaq GlobeNewswire

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program

19 أكتوبر 2023 15:01:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

19 أكتوبر 2023 09:26:51 بحسب NetDania Notify

Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society

10 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

09 أكتوبر 2023 12:23:58 بحسب NetDania Notify

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

05 أكتوبر 2023 12:33:04 بحسب NetDania Notify

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

03 أكتوبر 2023 09:14:58 بحسب NetDania Notify

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

02 أكتوبر 2023 09:36:32 بحسب NetDania Notify

Capricor Therapeutics Announces $23 Million Registered Direct Offering

29 سبتمبر 2023 06:35:51 بحسب Nasdaq GlobeNewswire